Figures
Figure S10-S13 S21
UV-Vis spectra of 2, 3, 6, 8, 9, 10, 13.
Figures S14-S18 S23
HR-MS spectra of 9, 10, 11, 13 and 14. 
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S5 resolution was optimized at 30'000 FWHM in the active focus mode. The accuracy was better than 2 ppm in a mass range between m/z 118 and 1600.
Spectroscopy: UV-Vis spectra were recorded on a Varian Cary 50 using quartz cells with a path length of 1 cm. Citation of λ max (log ε) in nm. For platelet studies, spectra were recorded on a Perkin Elmer double beam spectrophotometer Lambda 950 using quartz cells with a 1 cm path length. The kinetics of carbon monoxide release from CO donor compounds were studied by recording spectra at the Soret band region ( max = 424 nm) and observing the conversion from deoxyMb to MbCO at room temperature. Solutions of Mb (Myoglobin from equine heart, SIGMA) were prepared fresh by dissolving the protein in deionized water in such amount to obtain final concentrations 10 or 100 µM. Sodium dithionite (1 mg/ml, eq. 0.1%) was added just before measurements to convert myoglobin to deoxyMb. Before every experiment the reference spectra of deoxygenated protein were recorded. Solutions of CO donor compounds dissolved in DMSO:PBS (50:50) were added to the quartz cuvettes with deoxyMb in such amounts to give final concentrations of 10 or 100 µM. All solutions were always overlaid with mineral oil (0.5 cm 3 ) to prevent CO escaping and myoglobin being oxygenated. 1 H-and 13 C-NMR as well as 2D-NMR spectra were recorded on a 500 MHz Oxford NMR AS 500 using a QNP probe head and MestReNova 6.0.2 as evaluation tool. All spectra were recorded in D 2 O at 300 K and TSP was used as a reference for all 13 C-NMR experiments. 
Cyanocobalamin-c-lactone--CN-[Re(CO) 2
Br 2 (CH 3 OH)] (9). 2 (15.9 mg, 12 μmol, 1 equiv) and 1 (20 mg, 29 μmol, 2.4 equiv) were dissolved in methanol (10 mL) and stirred at 50ºC for 90 minutes. The solvent was subsequently removed and the resulting red powder was washed several times with dichloromethane (20 mL) and acetone (20 mL). 9 was obtained as a red microcrystalline powder (16.5 mg, 9 μmol, 75% 
10-bromo-cyanocobalamin--CN-[Re(CO) 2 Br 2 (CH 3 OH)]
(10). 3 (8 mg, 5.5 μmol, 1 equiv) and 1 (10 mg, 14 μmol, 2.5 equiv) were dissolved in methanol (7 ml) and stirred for 30 minutes at 50 ºC. The solvent was subsequently removed and the resulting red powder was washed several times with dichloromethane (20 mL) and acetone (20 mL). 10 was obtained as a dark red microcrystalline powder (7.5 mg, 4 μmol, 66% 
10-chloro-cyanocobalamin-c-lactone--CN-[Re(CO) 2
Br 2 (CH 3 OH)] (12). 5 (6.5 mg, 5 μmol, 1 equiv) and 1 (8 mg, 11 μmol, 2.2 equiv) were dissolved in methanol (6 mL) and the mixture was stirred for 20 minutes at 50 ºC. The solvent was subsequently removed and the resulting red powder was washed several times with dichloromethane (15 mL) and acetone (15 mL). 12 was obtained as a dark purple microcrystalline powder (7.9 mg, 4 μmol, 80%). 1.9  0.4 14 > 3 a Assuming a first order exponential decay (hours). 
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